The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma

Cytochrome P2C (CYP2C) subfamily members (CYP2C8,CYP2C9,CYP2C18, and CYP2C19) are known to participate in clinical drug metabolism. However, the association between CYP2C subfamily members and hepatocellular carcinoma (HCC) remains unclear. This study investigated the prognostic value of CYP2C subfa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Wang, Xiangkun, Yu, Tingdong, Liao, Xiwen, Yang, Chengkun, Han, Chuangye, Zhu, Guangzhi, Huang, Ketuan, Yu, Long, Qin, Wei, Su, Hao, Liu, Xiaoguang, Peng, Tao
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5911570/
https://ncbi.nlm.nih.gov/pubmed/29479826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1299
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi